Neuburgh Advisers’s Cross Country Healthcare CCRN Stock Holding History

Neuburgh Advisers’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$56K	Buy	5,392 +1,072	+25%	+$10.5K	﹤0.01%	840
2019 Q2	$41K	Hold	4,320	–	–	﹤0.01%	868
2019 Q1	$30K	Hold	4,320	–	–	﹤0.01%	873
2018 Q4	$32K	Hold	4,320	–	–	﹤0.01%	847
2018 Q3	$38K	Buy	4,320 +656	+18%	+$6.7K	﹤0.01%	862
2018 Q2	$41K	Hold	3,664	–	–	﹤0.01%	855
2018 Q1	$41K	Hold	3,664	–	–	﹤0.01%	863
2017 Q4	$47K	Buy	3,664 +992	+37%	+$13.1K	﹤0.01%	858
2017 Q3	$38K	Buy	2,672 +448	+20%	+$5.61K	﹤0.01%	855
2017 Q2	$29K	Buy	2,224 +1,168	+111%	+$15K	﹤0.01%	858
2017 Q1	$15K	Buy	1,056 +176	+20%	+$2.59K	﹤0.01%	864
2016 Q4	$14K	Buy	+880	New	+$12.1K	﹤0.01%	840

Other funds holding CCRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BSP

Benefit Street Partners New York $69.6M AUM

Neuburgh Advisers's CCRN Position: Q3 2019 in Review

Neuburgh Advisers increased its Cross Country Healthcare (CCRN) stake by 25% in Q3 2019, buying an estimated $10.5K and bringing the position to 5,392 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #840.

Neuburgh Advisers first reported a position in CCRN in Q4 2016 and has held it in 12 quarters since. 132 funds tracked by Wall St. Rank hold CCRN as of Q3 2019.

Neuburgh Advisers held 5,392 shares of Cross Country Healthcare worth $56K as of Q3 2019.
Neuburgh Advisers bought 1,072 Cross Country Healthcare shares in Q3 2019, an estimated $10.5K.
Cross Country Healthcare made up ﹤0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #840 holding.
Neuburgh Advisers first reported a position in Cross Country Healthcare in Q4 2016 and has held it in 12 quarters since.
132 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.